Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel two-step method for Rosuvastatin intermediate offers high yield and reduced environmental impact for pharmaceutical manufacturing supply chains.
Patent CN105175317A reveals advanced sodium picosulfate synthesis with high yield. Discover supply chain advantages and cost reduction in pharmaceutical manufacturing.
Patent CN117402085A reveals high-yield route for Sacubitril intermediate. Reduces cost and improves supply chain reliability for global pharma manufacturers.
Patent CN102241553B reveals a robust Pd-catalyzed method for biaryl synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN110204431A enables continuous flow photochemistry for high purity intermediates. Reduces cost and improves supply chain reliability for global pharmaceutical manufacturing.
Patent CN105273023B enables high-purity cytarabine prodrug synthesis without chromatography ensuring cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN113087691A details a Pd-catalyzed kinetic resolution for chiral aryl tertiary alcohols. Discover cost-effective routes for high-purity pharmaceutical intermediates.
Efficient preparation of Eltrombopag intermediate via palladium-free cyclization reducing costs and environmental impact for API manufacturing.
Patent CN1027503C details a superior crystalline salt form of 4-(di-n-propyl)amino-6-aminocarbonyl-1,3,4,5-tetrahydrobenzo[cd]indole, offering enhanced purity and scalable manufacturing for CNS drug development.
Patent CN1531523A reveals solvent-free hydrogenation using modifiers for cost-effective diamine manufacturing supply chain optimization and reduced environmental waste disposal burdens significantly.
Novel patent CN118459486A enables high-purity crisaborole impurity synthesis. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Advanced preparation method for high-purity Imatinib exceeding 99.5% purity. Optimized solvent recycling and mild conditions ensure cost reduction in pharmaceutical manufacturing.
Novel one-pot synthesis of difluoromethylsulfurized flavonoids via patent CN110294730A. Reduces cost and simplifies supply chain for pharmaceutical intermediates.
Patent CN108290910B reveals a stable synthesis route for ruthenium catalyst ligands, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Discover the organocatalytic synthesis of chromanone spiro indole intermediates. A cost-effective, metal-free route for oncology drug discovery and development.
Patent CN108473418A reveals a safer chiral resolution method for sulfonamide derivatives. Discover cost-effective manufacturing and reliable supply chain solutions for high-purity intermediates.
Patent CN111320577A reveals a scalable 5-step synthesis for Vadadustat intermediates, eliminating column chromatography and significantly reducing manufacturing costs for pharmaceutical supply chains.
Novel titanium-catalyzed oxidation method ensures high purity esomeprazole intermediates with scalable industrial production capabilities for global supply chains.
Explore the novel synthesis of N-substituted thiomorpholine derivatives for diabetes treatment. Discover cost-effective manufacturing and scalable supply chain solutions for high-purity DPP-IV inhibitors.
Patent CN111732528A details a metal-free CDC route for N-aryl indolines using nitrobenzene. Offers high yields up to 97% and scalable production for pharma intermediates.